Clinical trials
Completed Vulvar Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Gynecologic Oncology Group | 5 |
| Ohio State University Comprehensive Cancer Center | 4 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Abramson Cancer Center at Penn Medicine | 2 |
| Alliance for Clinical Trials in Oncology | 2 |
| Case Comprehensive Cancer Center | 2 |
| Dana-Farber Cancer Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| Regeneron Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vulvar Neoplasms | 57 |
| Uterine Cervical Neoplasms | 47 |
| Vaginal Neoplasms | 39 |
| Endometrial Neoplasms | 27 |
| Fallopian Tube Neoplasms | 23 |
| Ovarian Neoplasms | 21 |
| Carcinoma, Ovarian Epithelial | 18 |
| Breast Neoplasms | 17 |
| Anus Neoplasms | 16 |
| Penile Neoplasms | 15 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.